JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koch, W.
Right arrow Articles by Tatsch, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koch, W.
Right arrow Articles by Tatsch, K.
Journal of Nuclear Medicine Vol. 46 No. 7 1109-1118
© 2005 by Society of Nuclear Medicine


Clinical Investigations

Clinical Testing of an Optimized Software Solution for an Automated, Observer-Independent Evaluation of Dopamine Transporter SPECT Studies

Walter Koch, MD1, Perry E. Radau, PhD2, Christine Hamann, MD3 and Klaus Tatsch, MD1

1 Department of Nuclear Medicine, University of Munich, Munich, Germany
2 Department of Medical Biophysics, Sunnybrook & Women’s College Health Sciences, Toronto, Ontario, Canada
3 Department of Neurology, University of Munich, Munich, Germany

A lack of standardized evaluation procedures for dopamine transporter (DAT) SPECT investigations impairs both intra- and interindividual comparisons as well as multicenter trials—for example, for assessment of disease progression or the response to various drug treatments. Therefore, the aim of this study was to evaluate a novel automated method, which has been specifically developed for a standardized quantification of N-(3-fluoropropyl)-2ß-carbomethoxy-3ß-(4-iodophenyl)nortropane (123I-FP-CIT) SPECT studies. Methods: DAT binding ratios of 155 123I-FP-CIT SPECT studies in 14 control subjects and 141 patients referred to confirm or exclude a presynaptic dopaminergic deficit were determined manually and by a fully automated technique. The latter included coregistration of patient studies to an 123I-FP-CIT mean template of controls with specialized, nonrigid adjustment for variation in striatal location, followed by calculation of specific striatal DAT binding using a standardized 3-dimensional volume-of-interest (VOI) map. The map is based on a MR scan and covers the striatum (S), caudate (C), putamen (P), and an occipital reference region. The semiquantitative ratios of both methods were compared with the visual findings. Results: Excellent linear correlations were observed between manually and automatically determined results (S: r = 0.99; C: r = 0.99; P: r = 0.99; P < 0.001, respectively). Automated evaluations delivered highly reproducible and visually exact coregistrations. Individual variations in striatal anatomy (e.g., atrophy) were considered and VOI positions were corrected before quantification. Both the manual and the automated method showed identical accuracy in supporting the visual diagnoses. Conclusion: In a large patient population, excellent agreement was observed between quantitative DAT results using a time-consuming, observer-dependent, conventional manual method and the objective, automated evaluation specifically developed for a standardized evaluation of 123I-FP-CIT SPECT studies. It is suggested that the novel automated technique may substantially facilitate both intra- and interindividual comparisons as well as multicenter trials.

Key Words: quantitative evaluation • FP-CIT • automatic data processing • dopamine transporter




This article has been cited by other articles:


Home page
JNMHome page
I. G. Zubal, M. Early, O. Yuan, D. Jennings, K. Marek, and J. P. Seibyl
Optimized, Automated Striatal Uptake Analysis Applied to SPECT Brain Scans of Parkinson's Disease Patients
J. Nucl. Med., June 1, 2007; 48(6): 857 - 864.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
W. Koch, O. Pogarell, G. Popperl, J. Hornung, C. Hamann, F.-J. Gildehaus, K. Seelos, D. Lewis, A. Favit, and K. Tatsch
Extended Studies of the Striatal Uptake of 99mTc-NC100697 in Healthy Volunteers
J. Nucl. Med., January 1, 2007; 48(1): 27 - 34.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
W. Koch, C. Hamann, J. Welsch, G. Popperl, P. E. Radau, and K. Tatsch
Is Iterative Reconstruction an Alternative to Filtered Backprojection in Routine Processing of Dopamine Transporter SPECT Studies?
J. Nucl. Med., November 1, 2005; 46(11): 1804 - 1811.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2005 by the Society of Nuclear Medicine.